Skip to main content

Glen Eagle Advisors, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 2029317 KINGSTON, NJ

Position in TEVA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,776
+$1,957 QoQ
Shares Held
200
+25.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#593
of 671 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Glen Eagle Advisors, LLC holds $194,745 across 6 Drug Manufacturers - Specialty & Generic names. TEVA ranks #5 (3.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 TEVA
Teva Pharmaceutical Industries Ltd
This page
200 $6,776

All Filings in TEVA

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,776 200
2026-03-31 $4,819 160
2025-12-31 $4,993 160
2025-09-30 $3,232 160
2025-06-30 $2,681 160
2025-03-31 $2,459 160
2024-12-31 $3,526 160
2024-09-30 $2,883 160
2024-06-30 $2,600 160
2024-03-31 $2,257 160
2023-12-31 $1,670 160
2023-09-30 $1,632 160
2023-06-30 $1,204 160
2023-03-31 $1,416 160
2022-12-31 $1,459 160
2022-09-30 $1,291 160
2020-12-31 $3,377 350
2020-09-30 $3,153 350
2020-06-30 $4,315 350
2020-03-31 $1,347 150